SB
Serge Belanger Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
99
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $35 |
140%
upside
| 3 | +2.9% |
0
%
| 9 Jan ‘26 11 days ago |
|
|
|
Buy
Maintained
| $30 |
57%
upside
| 1 | -5.7% |
0
%
| 9 Jan ‘26 11 days ago |
|
|
|
Buy
Maintained
| $15 |
121%
upside
| 2 | +5.6% |
0
%
| 8 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $56 |
23%
upside
| 2 | +23% |
0
%
| 8 Jan ‘26 12 days ago |
|
|
|
Hold
Reiterated
| – | – | 1 | +0.79% |
0
%
| 24 Dec ‘25 26 days ago |
|
|
|
Buy
Maintained
| $42 |
26%
upside
| 1 | +33% |
0
%
| 23 Dec ‘25 27 days ago |
|
|
|
Buy
Maintained
| $84 |
34%
upside
| 2 | +7.5% |
0
%
| 22 Dec ‘25 28 days ago |
|
|
|
Buy
Reiterated
| $20 |
77%
upside
| 1 | +9.4% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Hold
Reiterated
| – | – | 1 | +0.54% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $36 |
43%
upside
| 1 | +20% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $34 |
30%
upside
| 2 | -1.3% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $46 |
45%
upside
| 1 | +15% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $18 |
170%
upside
| 1 | +2.5% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $52 |
37%
upside
| 1 | +14% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $55 |
38%
upside
| 1 | +6% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $30 |
16%
upside
| 1 | +15% |
0
%
| 28 Oct ‘25 2 months ago |
|